Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 7, 2012, Pages 941-946

  Rasslan, O ^a   Hafez, S F ^a   Hashem, Mohamed ^b   Ahmed, O I ^a   Faramawy, M A S ^c   Khater, W S ^a   Saleh, D A ^d   Mohamed, M I ^e   Khalifa, M A M ^e   Shoukry, F A ^e   El Moghazy, E H ^e  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

^e MINISTRY OF HEALTH   (Egypt)

Author keywords

BACTEC MGIT 960; Egypt; MDR TB; MODS; Mycobacterium tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; AGED; ARTICLE; ASSAY; BACTERIUM DETECTION; BACTERIUM ISOLATION; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY ASSAY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANTITUBERCULAR AGENTS; EGYPT; FEMALE; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84862211443     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0547     Document Type: Article

References (24)

1. World Health Organization. Global tuberculosis control: a short update to the 2009 report. WHO/HTM/TB/2009.426. Geneva, Switzerland: WHO; 2009.
2. National Tuberculosis Control Programme, Arab Republic of Egypt, Ministry of Health & Population. Tuberculosis control guide. Cairo, Egypt: Directorate General for Chest Diseases, 1998.
3. World Health Organization. Tuberculosis services in partnership. The case of Egypt. WHO-EM/TUB/243/E. Amsterdam, The Netherlands, and Cairo, Egypt: National Tuberculosis Control Programme, Egypt, World Health Organization, Eastern Mediterranean Region & Royal Tropical Institute, 2004.
4. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB). 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO, 2010.
5. World Health Organization. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-t uberculosis Drug Resistance Surveillance, 1994-1997. WHO/ TB/97.229. Geneva, Switzerland: WHO, 1997.
6. Sethi S, Sharma S, Sharma S K, et al. Drug susceptibility of Mycobacterium tuberculosis to primary anti-tubercular drugs by nitrate reductase assay. Indian J Med Res 2004; 120: 468-471. (Pubitemid 40044917)
7. National Tuberculosis Control Programme Egypt. Strategic plan 2007-2011. Cairo, Egypt: Egyptian Ministry of Health, National Tuberculosis Control Programme Egypt, 2006.
8. Pai M, Minion J, Sohn H, et al. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med 2009; 30: 701-716.
9. Meeting the challenge of multidrug-resistant tuberculosis: summary of a conference. MMWR Recomm Rep 1992; 41(RR-11): 51-57.
10. Paramasivan C N, Venkataraman P. Drug resistance in tuberculosis in India. Indian J Med Res 2004; 120: 377-386. (Pubitemid 39504473)
11. World Health Organization. The use of liquid medium for culture and DST. Geneva, Switzerland: WHO, 2007. http://www.who.int/tb/dots/laboratory/policy/en/ index3.html Accessed March 2012.
12. Caviedes L, Lee T S, Gilman R H, et al. Rapid, effi cient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clin Microbiol 2000; 38: 1203-1208. (Pubitemid 30140586)
13. Moore D A, Mendoza D, Gilman R H, et al., and the Tuberculosis Working Group in Peru. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 2004; 42: 4432-4437. (Pubitemid 39362351)
14. Park A G, Bishai W R, Chaisson R E, et al. Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 4750-4752. (Pubitemid 35434981)
15. Roggenkamp A, Hornef M W, Masch A, et al. Comparison of MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria in a routine diagnostic laboratory. J Clin Microbiol 1999; 37: 3711-3712. (Pubitemid 29491121)
16. Tortoli E, Cichero P, Piersimoni C, et al. Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study. J Clin Microbiol 1999; 37: 3578-3582. (Pubitemid 29491095)
17. Hanna B A, Ebrahimzadeh A, Elliott L B, et al. Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol 1999; 37: 748-752. (Pubitemid 29091296)
18. Alcaide F, Benítez M A, Escribà J M, et al. Evaluation of the BACTEC MGIT 960 and the MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA AccuProbe. J Clin Microbiol 2000; 38: 398-401. (Pubitemid 30043325)
19. Moore D A, Evans C A, Gilman R H, et al. Microscopico bservation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355: 1539-1550. (Pubitemid 44547806)
20. Mayta H, Gilman R H, Arenas F, et al., and the Tuberculosis Working Group in Peru. Evaluation of PCR-based universal heteroduplex generator assay as a tool for rapid detection of multidrug-resistant Mycobacterium tuberculosis in Peru. J Clin Microbiol 2003; 41: 5774-5777. (Pubitemid 37543285)
21. Shiferaw G, Woldeamanuel Y, Gebeyehu M, et al. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 1093-1097. (Pubitemid 46626469)
22. Arias M, Mello F C, Pavón A, et al. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis 2007; 44: 674-680.
23. Reddy K P, Brady M F, Gilman R H, et al. Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. Clin Infect Dis 2010; 50: 988-996.
24. Ejigu G S, Woldeamanuel Y, Shah N S, Gebyehu M, Selassie A, Lemma E. Microscopic-observation drug susceptibility assay provides rapid and reliable identifi cation of MDR-TB. Int J Tuberc Lung Dis 2008; 12: 332-337. (Pubitemid 351361906)